CRISPR Therapeutics AG (CRSP) Revenue (2016 - 2026)
CRISPR Therapeutics AG (CRSP) reported Revenue of $10.18 million for Q2 2026, compared with $892,000 a year earlier and up 598.3% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Revenue (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CRISPR Therapeutics AG's Revenue came in at $13.39 million, down 64.8% year-over-year; for FY2025, it came in at $3.51 million, down 90.6% from FY2024.
- Revenue has a five-year compound annual growth rate of 37.3% (FY2020 to FY2025).
- By year, Revenue came in at $37.31 million in FY2024 (-89.9%), $371.21 million in FY2023, $1.2 million in FY2022 (-99.9%) and $914.96 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Revenue since Q4 2024.
- Year over year, Revenue gained in four of the last six quarters, with growth averaging 13.4%.
- The high point for year-over-year Revenue in five years was Q3 2021 (growth of 456.8%); the low point was Q2 2022 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.46 million (Q1 2026), $864,000 (Q4 2025) and $889,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | CRISPR Therapeutics AG | 5.41 Bn | 5.41 Bn | - | 10.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.18 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 864,000.00 |
| Sep 30, 2025 | 889,000.00 |
| Jun 30, 2025 | 892,000.00 |
| Mar 31, 2025 | 865,000.00 |
| Dec 31, 2024 | 35.69 Mn |
| Sep 30, 2024 | 602,000.00 |
| Jun 30, 2024 | 517,000.00 |
| Mar 31, 2024 | 504,000.00 |
| Dec 31, 2023 | 201.21 Mn |
| Jun 30, 2023 | 70.00 Mn |
| Mar 31, 2023 | 100.00 Mn |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 94,000.00 |
| Jun 30, 2022 | 158,000.00 |
| Mar 31, 2022 | 940,000.00 |
| Dec 31, 2021 | 12.90 Mn |
| Sep 30, 2021 | 824,000.00 |
| Jun 30, 2021 | 900.70 Mn |
API Access
CRISPR Therapeutics AG Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();